Please login to the form below
companion diagnostic
This page shows the latest companion diagnostic news and features for those working in and with pharma, biotech and healthcare.
Liver specialist Genfit files $120m IPO on Nasdaq
Funds will go towards NASH candidate, a companion diagnostic and a liver disease drug. ... diagnostic for NASH to identify patients suitable for treatment with its drug, with another $6m set aside for testing the drug in combination regimens.
Latest news
-
Loxo, Bayer get FDA okay for biomarker-driven cancer drug
At the moment there is no companion diagnostic for NTRK fusions so patients need to be identified through genomic profiling techniques such as immunohistochemistry or genetic sequencing approaches, which tend to ... To try to address the diagnostic issue,
-
Loxo, Bayer get quick FDA review for ‘precision’ cancer drug
To try to address that issue, Loxo formed a partnership earlier this year with Illumina to develop a companion diagnostic – called TruSight Tumour 170 – that will use sequencing to identify whether
-
EMA starts firming up its stance on personalised medicines
The European Medicines Agency (EMA) hopes that when finalised they will help optimise the co-development of medicines and companion diagnostics. ... As diagnostic medical devices, companion diagnostics do not fall within the oversight of the EMA, but the
-
Celgene, Agios get FDA OK for leukaemia drug Idhifa
A companion diagnostic from Abbott Labs that detects mutations in the IDH2 gene in blood or bone marrow samples has been approved alongside the new drug.
-
AZ takes Chi-Med’s kidney cancer drug into phase III
He noted that the company has developed a companion diagnostic that will be used to select patients for its phase III programme.
More from news
Approximately 1 fully matching, plus 54 partially matching documents found.
Latest Intelligence
-
Drug launches to watch in 2019
At the moment there is no companion diagnostic for NTRK fusions so patients need to be identified through genomic profiling techniques such as immunohistochemistry or genetic sequencing approaches, which tend to
-
Harnessing complexity
This delicate balance between companion diagnostics' clinical utility and their potential confounding impact on patient treatment is a growing dilemma. ... Answering this question in full requires a scientific journey to better understand what a
-
Diagnostics are rising up the pharma value chain
Diagnostic drivers. It's not just this idea of changing public attitudes that is creating renewed interest in the diagnostics sector; the sector is also influenced by the wider forces affecting ... GlaxoSmithKline and Boehringer Ingelheim have had
-
Deal Watch table for June 2014
50. NanoString Technologies/ Celgene. Development. Development of a companion diagnostic assay.
-
Pharma deals during June 2014
a deal with NanoString Technologies for the development of a companion diagnostic assay to support the development of Revlimid for treatment of Diffuse Large B-Cell Lymphoma at a more modest
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Mastering the precision medicine opportunity
Novartis and Roche are two champions of personalised medicine, shaping the area with the launch of targeted treatments combined with a companion diagnostic to support patient identification. ... approval of their new FoundationOne CDx, the first and
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
-
Account Director, Medical Education
-
Salary TBC
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Senior Medical Writer
-
Competitive salary and benefits
-
Director – Healthcare PR
-
Salary TBC
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Salary TBC
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
Subscribe to our email news alerts
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
- The Pharma Brand Planners’ Blog: Part 1
- Novartis makes case for gene therapy Zolgensma in SMA
- Adding different perspectives to scientific communications at Porterhouse Medical
- Hemlibra off to a flyer as Roche raises 2019 forecasts
PMHub
Clark Health Communications
Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
